Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

Epic Investment Partners Views: The Week Ahead

This week’s US job report (Fri), the last before the final FOMC meeting this year, will be closely scrutinised. Other highlights this week include the NATO foreign minister gathering (Tue-Wed), the delayed OPEC meeting (Thu), and appearances from some key central bank figures throughout the week.  

Later today we have the eurozone manufacturing PMI and employment figures, UK S&P Global/CIPS manufacturing PMI and US ISM manufacturing readings. The China Caixin Services PMI, eurozone PPI and the S&P Global services PMI, and US factory orders and durable good prints will be of interest on Wednesday, as will the OECD economic outlook. Eurozone retail sales, Germany factory orders and US initial jobless claims are due on Thursday. Eurozone GDP, Germany industrial production and the US employment report and Uni. of Michigan sentiment prints will keep markets busy on Friday.  

Central bank chatter includes the ECB’s President Lagarde, and the Fed’s Williams and Waller today. The BoE’s Bailey, ECB’s Cipollone (and again on Wed) and Fed’s Kugler and Goolsbee speak at separate events on Tuesday. The Fed Chair Powell and ECB’s Lagarde and Musalem speak on Wednesday. The BoE’s Greene follows on Thursday. The Fed’s Bowman, Hammock, Goolsbee and Daly all appear on Friday.  

Another mixed week for markets amid Trump’s decision to pick Scott Bessent as US Treasury secretary and the president-elect’s announcement of new tariffs on Chinese, Mexican, and Canadian goods, ranging from 10-25%. The yield on the 10-year UST enjoyed a 23bpd fall to 4.17% while the S&P Index rallied a further 1.06%. Brent crude fell 2.97% to $72.94pb; OPEC could therefore announce an extension to production costs this week to support oil prices. The dollar benefited from tariff threats, the DXY Index gained 0.56%. 

As expected, US October PCE rose 2.3%yoy slightly higher than September’s 2.1%yoy print, while core PCE climbed to 2.8%yoy, from 2.7%yoy a month earlier. The second estimate of Q3’24 GDP remained unchanged at 2.8% annualised, though private consumption growth was revised lower from 3.7% to 3.5%. Personal spending growth moderated, increasing just 0.4% nominally and 0.1% in real terms, compared to September’s more robust 0.6% and 0.5%, respectively. Counterbalancing the spending slowdown, personal income grew 0.6% in October, up from 0.3% in September. Labor market indicators remained stable, with initial and continuing jobless claims showing little variation from the previous week. Preliminary October durable goods orders increased by 0.2%, recovering from September’s -0.4% decline, though falling short of expectations. Overall, the data suggests an economy experiencing a soft but still resilient growth pattern. 

The FOMC minutes from the November meeting revealed significant internal disagreement about the neutral interest rate. While Fed officials expressed uncertainty about potential future rate cuts, they emphasised that monetary policy decisions remain contingent on evolving economic conditions. The FOMC minutes did not introduce substantial new insights about inflation and growth, but the Committee’s confidence that inflation would eventually return to the 2% target provided some market reassurance. They also signalled an intention to reduce the overnight reverse repo rate by 5bps to align with the Fed funds’ rate target range. 

Elsewhere, China’s government bond yields declined last week, with the 10-year benchmark yield touching a multi-decade low of 2.02%. The rally was driven by expectations of a Reserve Ratio Requirement (RRR) cut and weak economic fundamentals. While industrial profits remained weak, sentiment improved, with the manufacturing PMI rising to 50.3 and the business expectation index jumping to 54.7. However, pricing pressures persisted, and the construction PMI fell to 49.7.  This morning’s Caixin manufacturing PMI print rose to 51.5 in November, the highest since July, supported by improved supply, demand and export orders. This suggests the pro-growth policies and stimulus measures implemented since September have bolstered market and business sentiment. 


Epic Investment Partner’s Key risks & Disclaimers:

EPIC Global Equity Fund (the “Fund”) is a sub-fund of EPIC Funds p.l.c. (the “Company”), which is an open-ended umbrella fund authorised in Ireland as a UCITS fund and regulated by the Central Bank of Ireland. This marketing material has been approved in the UK by EPIC Markets (UK) LLP, trading as EPIC Investment Partners, which is a limited liability partnership incorporated and registered in England and Wales under partnership OC306260 with its registered office at Audrey House, 16-20 Ely Place, London EC1N 6SN. EPIC Markets (UK) LLP is regulated by the Financial Conduct Authority. Distribution of this material and the offer of the Fund are specifically restricted in certain jurisdictions. In particular, but without limitation, neither this material nor shares in the Fund are available to US persons.

This document is for general information purposes only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. It is not a personal recommendation and it should not be regarded as a solicitation or an offer to buy or sell any shares in the Fund. This document represents the views of EPIC Investment Partners at the time of writing. It should not be construed as investment advice. Any person interested in investing in the Fund should conduct their own investigation and analysis of the Fund and should consult their own professional tax, accounting or other advisers as to the risks involved in making such an investment. Full details of the Fund’s investment objectives, investment policy and risks are set out in the Fund’s Prospectus and Supplement which, together with the Key Information Document (“KID”), are available on request and free of charge from Maples Fund Services (Ireland) Limited, 32 Molesworth Street, Dublin 2, Ireland and, in the UK, from EPIC Markets (UK) LLP, Audrey House, 16-20 Ely Place, London EC1N 6SN. Any offering of the Fund is only made on the terms of the current Prospectus, Supplement and KID. A subscription in the Fund can only be made after the provision of the KIID and should be made solely upon the information contained in the Prospectus, Supplement and KID.

An investment in the Fund is not suitable for an investor who cannot sustain a loss on their investment. There is no guarantee of the Fund’s future performance and past performance is not a reliable indicator of future performance. The value of your investment and the income derived from it can go down as well as up, and you may not get back the money you invested. The risks associated with making an investment in the Fund are described in the Prospectus and Supplement but investors should note, in particular, the following: 1) Foreign currency denominated investments are subject to fluctuations in exchange rates that could have a positive or an adverse effect on an investor’s returns. There is also a risk that currency hedging transactions for one share class may in extreme cases adversely affect the net asset value of the other share classes within the same sub-fund since there is no legal segregation between share classes; 2) The Fund is subject to the risk of the insolvency of its counterparties; and 3) Emerging market securities are subject to greater social, political, regulatory, and currency risks than developed market securities. This may impact the liquidity and value of such securities and, consequently, the value of the Fund.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from EPIC Investment Partners. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document is intended for retail clients however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

If you’re looking to save money during 2025, MeDirect has a wide range of options designed to suits the different needs and goals of customers.
All News

Saving Options in 2025 with MeDirect

If you’re looking to save money during 2025, MeDirect has a wide range of options designed to suits the different needs and goals of customers.

Three investment lessons from 2024
All News

BlackRock Commentary: Three investment lessons from 2024

The 2025 outlook emphasizes economic transformation over traditional cycles, offering opportunities to counter market misinterpretations of macro data while navigating surprises, volatility, and policy-driven shifts.

Epic Investment Partners Weekly Article
All News

Epic Investment Partners Views: The Week Ahead

The first full week of the year features key economic data releases, including the FOMC minutes, US employment report, global PMI and inflation readings, alongside central bank commentary, with markets focused on inflation control, labour market resilience, and evolving monetary policies from the Fed, ECB, BoE, and PBoC.

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 


Sign up and open your account for free, within minutes.

MeDirect_Multi-Devices-cards

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.